Speciality healthcare solutions company.
Issues relating to incentives for life sciences research.
Tax treatment of inverted companies.
Tax issues in mergers and acquisitions of US firms. Oversight of implementation of the America Invents Act.
Issues relating to patent settlements.
Patent reform.
Issues relating to misuse of the inter pares review process. Issues relating to prescription drug abuse.
Issues relating to incentives for tamper-resistant formulations.
Issues relating to FDA approvals of new drugs and generic drugs.
Issues related to the FDA.
Issues related to Opioids.
Issues relating to Medicare Part D rebates.
Issues relating to the labeling of generic drugs.
Issues relating to CDC guidance for prescribing opioids.
Issues relating to products containing high doses of acetaminophen.
Issues relating to removal of FDA unapproved products from the market.
Opioid abuse legislation.
Issues relating to prescription drug pricing.
Issues relating to the removal of Opana ER from the market.
Issues relating to illegal marketing of phenobarbital.
Issues related to FDA approval of adrenaline. Issues relating to Mass Torts and Class Action Reform.
TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues TOR - Torts
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE GIBSON GROUP, LLC
601 Thirteenth Street, N.W., Suite B2 North, Washington, DC, 20005, US
JOSEPH H GIBSON JOSEPH H GIBSON JOSEPH H GIBSON (Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997) JOSEPH H GIBSON
Counsel for Legislative & Intergovernmental Affairs Anti-Trust Division, DOJ 2001-2002; Chief Antitrust Counsel, House Judiciary Committee 1997-2001; Counsel, House Judiciary Committee 1995-1997